WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

GeneDx Holdings Corp. (NASDAQ: WGS) faces a securities investigation following disappointing Q1 2026 results, including a $57.5 million operating loss, $65 million revenue guidance cut, and a $31.3 million goodwill write-down for its Fabric Genomics unit. The stock plummeted 50% from $67.93 to $34.51 on May 5, 2026, following the May 4 earnings announcement.